Correlation Analysis of IL-17, IL-21, IL-23 with Non-Alcoholic Liver Fibrosis and Cirrhosis

References

• Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37–55. doi:10.1016/j.mam.2018.09.002
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151–166. doi:10.1038/s41575-020-00372-7
   PubMed Web of Science ®Google Scholar
• Yang F, Li H, Li Y, et al. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis. Int Immunopharmacol. 2021;99:108051. doi:10.1016/j.intimp.2021.108051
   PubMed Web of Science ®Google Scholar
• Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449–1457. doi:10.1016/j.hep.2003.09.022
   PubMed Web of Science ®Google Scholar
• Maybury CM, Samarasekera E, Douiri A, et al. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis. Br J Dermatol. 2014;170(6):1237–1247. doi:10.1111/bjd.12905
   PubMed Web of Science ®Google Scholar
• Cui J, Ang B, Haufe W, et al. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study. Aliment Pharmacol Ther. 2015;41(12):1271–1280. doi:10.1111/apt.13196
   PubMed Web of Science ®Google Scholar
• Aleknaviciute-Valiene G, Banys V. Clinical importance of laboratory biomarkers in liver fibrosis. Biochem Med (Zagreb). 2022;32(3):30501.
   Web of Science ®Google Scholar
• Larsen JB, Knudsen CS, Parkner T. Procollagen III, N-terminal propeptide (PIIINP): establishment of reference intervals in Northern European adults and children using the MAGLUMI 800 chemiluminescence immunoassay. Scand J Clin Lab Invest. 2021;81(5):389–393. doi:10.1080/00365513.2021.1929444
   PubMed Web of Science ®Google Scholar
• Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41(3):283–297. doi:10.1007/s00281-019-00733-8
   PubMed Web of Science ®Google Scholar
• Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol. 2011;2011:345803. doi:10.1155/2011/345803
   PubMedGoogle Scholar
• Ping Zhang X, Fei Shang X, Xiu Hui L. Progress in the diagnosis and treatment of hepatic fibrosis by combining traditional Chinese and western medicine. J Clin Hepatobil Dis. 2023;39(02):284–289.
   Google Scholar
• Wang SX. Diagnostic criteria and therapeutic options for liver cirrhosis. Chin Clin. 2000;2000(10):25–26.
   Google Scholar
• Nallagangula KS, Nagaraj SK, Venkataswamy L, et al. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA. 2018;4(1):FSO250. doi:10.4155/fsoa-2017-0083
   PubMed Web of Science ®Google Scholar
• Qi Di Z, Lun Geng L. Diagnostic value of serum markers for liver fibrosis. Dr Liver. 2022;2022:(02):28–29.
   Google Scholar
• Jothimani DKE. Performance of non-invasive markers of liver fibrosis. JCEH. 2018;6(413):s77.
   Google Scholar
• El-Mezayen HA, Habib S, Marzok HF, et al. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study. Eur J Gastroenterol Hepatol. 2015;27(4):378–385. doi:10.1097/MEG.0000000000000298
   PubMed Web of Science ®Google Scholar
• Lynch M, Higgins E, McCormick PA, et al. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis. JAMA Dermatol. 2014;150(8):856–862. doi:10.1001/jamadermatol.2013.9336
   PubMed Web of Science ®Google Scholar
• Rostami S, Parsian H. Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis. Hepat Mon. 2013;13(12):e13787. doi:10.5812/hepatmon.13787
   PubMed Web of Science ®Google Scholar
• Gawrieh S, Wilson LA, Yates KP, et al. Relationship of ELF and PIIINP with liver histology and response to vitamin E or pioglitazone in the PIVENS trial. Hepatol Commun. 2021;5(5):786–797. doi:10.1002/hep4.1680
   PubMed Web of Science ®Google Scholar
• Jorge A, Andrade J, Paraiso AF, et al. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity. Obes Res Clin Pract. 2018;12(Suppl 2):1–8. doi:10.1016/j.orcp.2016.03.009
   PubMed Web of Science ®Google Scholar
• Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64(6):1403–1415. doi:10.1016/j.jhep.2016.02.004
   PubMed Web of Science ®Google Scholar
• Buonomo EL, Mei S, Guinn SR, et al. Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages. J Hepatol. 2022;76(5):1127–1137. doi:10.1016/j.jhep.2021.12.036
   PubMed Web of Science ®Google Scholar
• Hou X, Yin S, Ren R, et al. Myeloid-cell-specific IL-6 signaling promotes MicroRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis. Hepatology. 2021;74(1):116–132. doi:10.1002/hep.31658
   PubMed Web of Science ®Google Scholar
• Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143(3):765–776. doi:10.1053/j.gastro.2012.05.049
   PubMed Web of Science ®Google Scholar
• Schurich A, Pallett LJ, Lubowiecki M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog. 2013;9(3):e1003208. doi:10.1371/journal.ppat.1003208
   PubMed Web of Science ®Google Scholar
• Rey I, Effendi-Ys R. Association between serum IL-6, IL-10, IL-12, and IL-23 levels and severity of liver cirrhosis. Med Arch. 2021;75(3):199–203. doi:10.5455/medarh.2021.75.199-203
   PubMedGoogle Scholar
• Xing X, Li A, Tan H, et al. IFN-γ + IL-17 + Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma. J Cell Mol Med. 2020;24(23):13600–13608. doi:10.1111/jcmm.15266
   PubMed Web of Science ®Google Scholar
• Feng G, Zhang JY, Zeng QL, et al. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells. Hepatol Res. 2014;44(10):E198–E205. doi:10.1111/hepr.12215
   PubMed Web of Science ®Google Scholar
• Zhao J, Shi J, Qu M, et al. Hyperactive follicular helper T cells contribute to dysregulated humoral immunity in patients with liver cirrhosis. Front Immunol. 2019;10:1915. doi:10.3389/fimmu.2019.01915
   PubMed Web of Science ®Google Scholar